Aerospace Technical Services Co. (ATS), a leading provider specializing in aircraft parts and components, as well as offering comprehensive maintenance, repair, and technical services for the...

At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L)...

Mature results from Medivir's phase 1b / 2a open label trial of fostrox + Lenvima® confirm improved outcomes in second-line advanced liver cancer with a median time to progression (TTP) of 10.9...

Organizations worldwide continue to understand the cloud native technology's role in driving innovation across industries VIENNA, Sept. 16, 2024 /PRNewswire/ -- Open Source Summit Europe – The...

TAR-200 plus cetrelimab effective in reducing tumor size in those with muscle-invasive disease, potentially improving surgical outcomes and lowering risk of recurrence BARCELONA, Spain, Sept. 16, 2024